1. Home
  2. EKSO vs PMN Comparison

EKSO vs PMN Comparison

Compare EKSO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$10.11

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$24.08

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EKSO
PMN
Founded
2005
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
34.6M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
EKSO
PMN
Price
$10.11
$24.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.50
$42.67
AVG Volume (30 Days)
154.8K
190.9K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.76
110.28
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$81.23
N/A
Revenue Next Year
$7.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.29
52 Week High
$13.27
$21.83

Technical Indicators

Market Signals
Indicator
EKSO
PMN
Relative Strength Index (RSI) 52.31 87.14
Support Level $8.71 $0.43
Resistance Level $10.76 N/A
Average True Range (ATR) 1.05 1.71
MACD -0.19 0.64
Stochastic Oscillator 29.52 98.91

Price Performance

Historical Comparison
EKSO
PMN

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: